Summary
The kinetics of metapramine and two of its demethylated metabolites were determined in six normal subjects after oral administration of a single 150 mg dose on day 1 and 3 × 50 mg dose on day 2–6. This study has shown that three demethylated metabolites are found in plasma beside metapramine. The monodemethylated metabolite I appeared to be the predominant one and the mean area under the plasma concentration curve (AUC 40 ) was 49% of the metapramine value. Its half-life was shorter (5,92 h) than that of metapramine (8,29 h). The kinetic profiles of metapramine and its major metabolites I and II were similar and data over 24 h could be fitted by a tri-exponential equation even though entero-hepatic cycles were observed. A high interindividual variability of data was found for both metapramine and its metabolites. There were no significant differences between men and women. The minimal plasma level (Cmin) seemed in agreement with the half-life of the drug.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dick P. (1978): Comparative study of the pharmacological and clinical effects of clorimipramine and metapramine (19560 RP). Encephale, 4,41–51.
Decouvelaere B., Terlain B. and Bieder A. (1982): Biotransformation of metapramine in three animal species (dog, rabbit, rat) and in man. Therapie, 37, 3, 249–257.
Sommadossi J.P., Lemar M., Necciari J., Sumirtapura Y., Cano J.P. and Gaillot J. (1982): High-performance liquid chromatographic method for the determination of plasma and urine metapramine after dansylation. J. Chromatogr., 228,205–213.
Bougerolle A.M., Chabard J.L., Bargnoux H., Petit J., Berger J.A. and Dordain G. (1985): Simultaneous determination of metapramine and its demethylated metabolites in plasma by gas chromatography — mass spectrometry. J. Chromatogr., 345, 59–66.
Gibaldi M. and Perrier D. (1982): Pharmacokinetics, ed. 2, Marcel Dekker, Inc., New York.
Sumirtapura Y., Leroux Y., Raj Komar A., Cano J.P. and Gaillot J. (1983): Pharmacokinetics of metapramine (19560 RP) in man after infusion and intraveinous injection. Eur. J. Clin. Pharmacol., 25, 673–680.
Bougerolle A.M., Chabard J.L., Dordain G., Gaillot J., Piron J.J. and Berger J.A. (1984): Compared bioavailability of three oral forms of metapramine in human volunteer. Therapie, 39, 6, 619–624.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bougerolle, A.M., Chabard, J.L., Dordain, G. et al. Kinetics of metapramine and its demethylated metabolites after single and chronic oral administration in man. European Journal of Drug Metabolism and Pharmacokinetics 11, 113–118 (1986). https://doi.org/10.1007/BF03189836
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189836